Peripheral Systemic Thrombolysis Versus Catheter Directed Thrombolysis for Submassive PE
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Azhar Supariwala, MD
Southside Northwell Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Southside Northwell Hospital
Bay Shore, New York, United States
- Long Island Jewish Medical Center
Queens, New York, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Jan 2019
- Primary completion
- 19 Mar 2023
- Completion
- 19 Mar 2025
- Last update posted
- 3 Oct 2024
- Registered enrollment
- 31
- Registry id
- NCT03581877
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 30 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.